COVID-19 Infection and Multiple Myeloma

Brief summary (registry, in English)

Collect in an observational study the outcomes of COVID19 infection in MM patients across Europe.

What you commit to

• Study type: Observational
• Participants enrolled: 1054
• From 1 Jul 2020 to the primary completion date, 18 Aug 2022
• 8 sites in 8 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 99 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.